Small Molecule BMP Inhibitors for Neural Precursor Differentiation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for differentiating pluripotent stem cells into neural precursor cells often result in residual undifferentiated cells and are costly due to the use of cytokines, with the efficiency of small molecule compounds for this differentiation remaining unknown.

Innovation Solution

A method involving the culture of pluripotent stem cells with small molecule BMP inhibitors, optionally combined with TGFβ family inhibitors, in the presence or absence of feeder cells, to efficiently induce differentiation into neural precursor cells, using specific compounds like Dorsomorphin and SB431542.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If cytokines are used to induce differentiation of pluripotent stem cells into neural precursor cells, then differentiation can be achieved, but the cost becomes very high

Engineering Contradiction:
Improvedifferentiation efficiencyVSAvoidcost
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent replaces expensive cytokines with small molecule compounds that are significantly cheaper and can be used in culture media. The small molecules serve as cost-effective alternatives to protein-based cytokines while achieving the desired differentiation effect.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the chemical parameters of the differentiation induction system by using small molecule compounds with specific molecular structures and properties instead of cytokines. This parameter change enables cost reduction while maintaining or improving differentiation efficiency.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If conventional differentiation methods are used, then neural precursor cells can be obtained, but undifferentiated cells remain after induction

Engineering Contradiction:
Improvedifferentiation efficiencyVSAvoiddifferentiation purity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent uses small molecule compounds at optimized concentrations to achieve complete differentiation. By adjusting the dosage and exposure time of the small molecules, the method ensures thorough differentiation of all pluripotent stem cells while avoiding residual undifferentiated cells.

Inventive Principle:
Principle #16Partial or excessive action

Solution Approach 2:

The method incorporates monitoring of differentiation status to ensure complete conversion of pluripotent stem cells to neural precursor cells. This feedback mechanism allows adjustment of culture conditions to eliminate undifferentiated cells while maintaining high differentiation efficiency.

Inventive Principle:
Principle #23Feedback

3Quantity of substance

If small molecule compounds are used to replace cytokines, then cost is reduced, but the efficiency of differentiation into neural cells remains unknown

Engineering Contradiction:
ImprovecostVSAvoiddifferentiation efficiency
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The small molecule compounds inherently possess the ability to induce neural differentiation without requiring additional complex factors or conditions. The molecules themselves provide all necessary signaling functions that previously required cytokines, achieving both cost reduction and reliable differentiation.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS10119120B2Method for inducing differentiation of pluripotent stem cells into neural precursor cells
Publication Date: 2018.11.06 KYOTO UNIV
  • US10119120B2 patent drawing
  • US10119120B2 patent drawing
  • US10119120B2 patent drawing

AI summary

The present invention provides a method for inducing differentiation of pluripotent stem cells into neural precursor cells, comprising culturing the pluripotent stem cells in the presence of a small molecule BMP inhibitor, and induced neural precursor cells prepared by this method.